<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35094663</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>02</Month>
        <Day>01</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>30</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Electronic">1743-2928</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>27</Volume>
            <Issue>1</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Redox report : communications in free radical research</Title>
          <ISOAbbreviation>Redox Rep</ISOAbbreviation>
        </Journal>
        <ArticleTitle>The emerging role of irisin in experimentally induced arthritis: a recent update involving HMGB1/MCP1/Chitotriosidase I-mediated necroptosis.</ArticleTitle>
        <Pagination>
          <StartPage>21</StartPage>
          <EndPage>31</EndPage>
          <MedlinePgn>21-31</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1080/13510002.2022.2031516</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Necroptosis is a tightly adjusted inflammatory necrotizing cell death signaling pathway that participates in pathogenesis of discrete diseases as rheumatoid arthritis (RA). Irisin is a myokine with immuno-modulatory effect. Evaluation of irisin efficiency as a novel therapeutic agent in experimentally induced RA via modulating immuno-inflammatory, necroptotic molecular and biochemical signaling pathways.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">RA was induced in 30 female Wister albino rats by a single subcutaneous injection of collagen-II with incomplete Freund's adjuvant (CII-IFA) followed by booster immunization dose 10 days later. After 14 days of the injection, arthritis chronic phase was precipitated. 15 rats were treated by S.C irisin injection daily for 4 weeks. Joint tissue homogenate RIPK-3, MLKL, HMGB1, MCP1, IL-6, CHIT1, MDA, and PN levels were assessed calorimetrically. However, TNF-α mRNA expression level was evaluated by the qrt-PCR technique.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">The results showed that irisin significantly decreases the level of all assessed biochemical parameters, except MDA, which was significantly increased in comparison with the correspondent values in the arthritic group with no treatment (ttt).</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Irisin exhibits therapeutic anti-inflammatory and antioxidant effects via modulating immuno-inflammatory, necroptotic molecular, and biochemical signaling pathways in experimentally induced RA in rats.</AbstractText>
          <AbstractText Label="ABBREVIATIONS" NlmCategory="BACKGROUND">RA: rheumatoid arthritis; RIPK3: receptor-interacting protein kinase 1; MLKL: mixed lineage kinase domain-like protein; HMGB1: High-mobility group protein box 1; MCP1: Monocyte chemoattractant protein 1; IL-6: Interleukin 6; CHIT1: Chitotriosidase; MDA: Malondialdehyde; PN: Peroxynitrite; TNF-α: Tumor Necrosis Factor; qrt-PCR: quantitative real-time reverse transcription PCR; CII-IFA: collagen-II with incomplete Freund's adjuvant; ttt: treatmentNote: <i>TNF-α</i> gene (NCBI GenBank Nucleotide accession # NM_012675.3); The housekeeping gene <i>GAPDH</i> (NCBI GenBank Nucleotide accession # NM_017008.4).</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Raafat Ibrahim</LastName>
            <ForeName>Rowida</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-6500-8156</Identifier>
            <AffiliationInfo>
              <Affiliation>Medical Biochemistry &amp; Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Shafik</LastName>
            <ForeName>Noha M</ForeName>
            <Initials>NM</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Biochemistry &amp; Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Esawy</LastName>
            <ForeName>Rasha Osama</ForeName>
            <Initials>RO</Initials>
            <AffiliationInfo>
              <Affiliation>Pharmacology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Sakaa</LastName>
            <ForeName>Mervat H</ForeName>
            <Initials>MH</Initials>
            <AffiliationInfo>
              <Affiliation>Physiology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Arakeeb</LastName>
            <ForeName>Heba M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Anatomy &amp; Embryology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>El-Sharaby</LastName>
            <ForeName>Radwa Mahmoud</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical pathology department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ali</LastName>
            <ForeName>Dina Adam</ForeName>
            <Initials>DA</Initials>
            <AffiliationInfo>
              <Affiliation>Clinical pathology department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Safwat El-Deeb</LastName>
            <ForeName>Omnia</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Biochemistry &amp; Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ragab Abd El-Khalik</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Medical Biochemistry &amp; Molecular Biology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Redox Rep</MedlineTA>
        <NlmUniqueID>9511366</NlmUniqueID>
        <ISSNLinking>1351-0002</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D018932">Chemokine CCL2</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D024243">HMGB1 Protein</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="C104200">Hbp1 protein, rat</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.-</RegistryNumber>
          <NameOfSubstance UI="D006596">Hexosaminidases</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 3.2.1.-</RegistryNumber>
          <NameOfSubstance UI="C086400">chitotriosidase</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName>
          <QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
          <QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D018932" MajorTopicYN="N">Chemokine CCL2</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024243" MajorTopicYN="Y">HMGB1 Protein</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006596" MajorTopicYN="N">Hexosaminidases</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000079302" MajorTopicYN="N">Necroptosis</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051381" MajorTopicYN="N">Rats</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Arthritis</Keyword>
        <Keyword MajorTopicYN="N">Irisin</Keyword>
        <Keyword MajorTopicYN="N">Monocyte chemoattractant protein 1</Keyword>
        <Keyword MajorTopicYN="N">RIPK1/3</Keyword>
        <Keyword MajorTopicYN="N">high-mobility group box 1</Keyword>
        <Keyword MajorTopicYN="N">necroptosis</Keyword>
        <Keyword MajorTopicYN="N">‌Chitotriosidase-1</Keyword>
      </KeywordList>
      <CoiStatement>No potential conflict of interest was reported by the author(s).</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>31</Day>
          <Hour>5</Hour>
          <Minute>33</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>1</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>2</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35094663</ArticleId>
        <ArticleId IdType="pmc">PMC8803109</ArticleId>
        <ArticleId IdType="doi">10.1080/13510002.2022.2031516</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Belizário J, Vieira-Cordeiro L, Enns S.. 
Necroptotic cell death signaling and execution pathway: lessons from knockout mice. Mediators Inflamm. 2015;2015:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4600508</ArticleId>
            <ArticleId IdType="pubmed">26491219</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Peltzer N, Walczak H.. 
Cell death and inflammation – a vital but dangerous liaison. Trends Immunol. 2019;40(5):387–402.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">31003931</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xingfeng Q, Yingying Z, Jiahuai H.. 
RIP3 is an upregulator of aerobic metabolism and the enhanced respiration by necrosomal RIP3 feeds back on necrosome to promote necroptosis. Cell Death Differ. 2018;25(5):821–824.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5943361</ArticleId>
            <ArticleId IdType="pubmed">29523873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roh JS, Sohn DH.. 
Damage-Associated molecular patterns in inflammatory diseases. Immune Netw. 2018;18(4):e27.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6117512</ArticleId>
            <ArticleId IdType="pubmed">30181915</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Martinotti S, Patrone M, Ranzato E.. 
Emerging roles for HMGB1 protein in immunity, inflammation, and cancer. Immunotargets Ther. 2015;4:101–109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4918250</ArticleId>
            <ArticleId IdType="pubmed">27471716</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>He M, Bianchi ME, Coleman TR, et al. . 
Exploring the biological functional mechanism of the HMGB1 / TLR4 / MD-2 complex by surface plasmon resonance. Mol Med. 2018;24(1):21.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6085627</ArticleId>
            <ArticleId IdType="pubmed">30134799</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Najafov A, Chen H, Yuan J.. 
Necroptosis and cancer. Trends Cancer. 2017;3(4):294–301.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5402749</ArticleId>
            <ArticleId IdType="pubmed">28451648</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oliveira SR, Amaral JD, Rodrigues CMP.. 
Mechanism and disease implications of necroptosis and neuronal inflammation. Cell Death Dis. 2018;9(9):903.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6125291</ArticleId>
            <ArticleId IdType="pubmed">30185777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shan B, Pan H, Najafov A, et al. . 
Necroptosis in development and diseases. Genes Dev. 2018;32(5-6):327–340.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5900707</ArticleId>
            <ArticleId IdType="pubmed">29593066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim Y, Oh HC, Jang Won Park JW, et al. . 
Diagnosis and treatment of inflammatory joint disease. Hip Pelvis. 2017;29(4):211–222.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5729162</ArticleId>
            <ArticleId IdType="pubmed">29250494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Guo Q, Wang Y, Xu D, et al. . 
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5920070</ArticleId>
            <ArticleId IdType="pubmed">29736302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Scanzello CR.
Chemokines and inflammation in osteoarthritis: insights from patients and animal models. J Orthop Res. 2017;35(4):735–739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5912941</ArticleId>
            <ArticleId IdType="pubmed">27808445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang YC, Soriano M, Hahn RA, et al. . 
Expression of cytokines and chemokines in mouse skin treated with sulfur mustard. Toxicol Appl Pharmacol. 2018;355:52–59.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6438172</ArticleId>
            <ArticleId IdType="pubmed">29935281</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Elmonem MA, van den Heuvel LP, Levtchenko EN.. 
Immunomodulatory effects of Chitotriosidase enzyme. Enzyme Res. 2016;2016:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4735922</ArticleId>
            <ArticleId IdType="pubmed">26881065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanneganti M, Kamba A, Mizoguchi E.. 
Role of chitotriosidase (chitinase 1) under normal and disease conditions. J Epithel Biol Pharmacol. 2012;5:1–9. PMID: 23439988.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3579558</ArticleId>
            <ArticleId IdType="pubmed">23439988</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hao F, Lee JR, Zhong L, et al. . 
Hybrid micelles containing methotrexate-conjugated polymer and co-loaded with microRNA-124 for rheumatoid arthritis therapy. Theranostics. 2019;9(18):5282–5297.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6691571</ArticleId>
            <ArticleId IdType="pubmed">31410215</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bubak MP, Heesch MWS, Shute RJ, et al. . 
Irisin and fibronectin type III domain-containing 5 responses to exercise in different environmental conditions. Int J Exerc Sci. 2017;10(5):666–680. PMID: 28966707.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5609670</ArticleId>
            <ArticleId IdType="pubmed">28966707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Munoz IYM, Romero ESC, Garcia JJG.. 
Irisin a novel metabolic biomarker: present knowledge and future directions. Int J Endocrinol. 2018;2018:1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6198573</ArticleId>
            <ArticleId IdType="pubmed">30402097</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bilski J, Mazur-Bialy A, Wojcik D, et al. . 
Effect of forced physical activity on the severity of experimental colitis in normal weight and obese mice. Involvement of oxidative stress and proinflammatory biomarkers. Nutrients. 2019;11(5):1127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6567060</ArticleId>
            <ArticleId IdType="pubmed">31117199</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saleh BO, Majeed MJ, Oreaby GM.. 
Irisin impact as a medication that ameliorate and hinder the development of insulin resistance associated disorders without regular exercise (experimental study). IOSR J Dent Med Sci. 2014 Sept;13(9):28–35. doi:10.9790/0853-13932835. Ver. III.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.9790/0853-13932835</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Trentham DE, Townes AS, Kang AH.. 
Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977;146:857–868. doi:10.1084/jem.146.3.857.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.146.3.857</ArticleId>
            <ArticleId IdType="pmc">PMC2180804</ArticleId>
            <ArticleId IdType="pubmed">894190</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carlson BC, Jansson ÅM, Larsson A, et al. . 
The endogenous adjuvant squalene can induce a chronic T-cell- mediated arthritis in rats. Am J Pathol. 2000;156:2057–2065.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1850095</ArticleId>
            <ArticleId IdType="pubmed">10854227</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rioja I, Bush KA, Buckton JB, et al. . 
Joint cytokine quantification in two rodent arthritis models: kinetics of expression, correlation of mRNA and protein levels and response to prednisolone treatment. ClinExpImmunol. 2004;137(1):65–73. doi:10.1111/j.1365-2249.2004.02499.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2249.2004.02499.x</ArticleId>
            <ArticleId IdType="pmc">PMC1809073</ArticleId>
            <ArticleId IdType="pubmed">15196245</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lowry OH,: Rosebrough NJ, Farr AL and Randall RJ.. 
Protein measurement with the Folin phenol reagent. J BiolChem. 1952;193(1):265–275. PMID:14907713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14907713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>El-Magd MA, Abbas HE, El-kattawy AM, et al. . 
Novel polymorphisms of the IGF1R gene and their association with average daily gain in Egyptian buffalo (Bubalus bubalis). Domest Anim Endocrinol. 2013;45(2):105–110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">23820243</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Livak KJ, Schmittgen TD.. 
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">11846609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hollak C, Weely S, Oers M, et al. . 
Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher disease. J Clin Invest. 1994;93(3):1288. doi:10.1172/JCI117084.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI117084</ArticleId>
            <ArticleId IdType="pmc">PMC294082</ArticleId>
            <ArticleId IdType="pubmed">8132768</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ohkawa H, Ohishi N, Yagi K.. 
Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95:351–358. doi:10.1016/0003-2697(79)90738-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0003-2697(79)90738-3</ArticleId>
            <ArticleId IdType="pubmed">36810</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Marwan S, Samir A, Khalid S.. 
Serum nitric oxide and peroxynitrite levels in adult sero-positive rheumatoid arthritis treated with disease modifying antirheumatic drugs: a preliminary report. Turk J Med Sci. 2010;40(2):191–197. doi:10.3906/sag-0809-32.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3906/sag-0809-32</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drury RA, Wallington EA.. 
Carletons histological technique. 5th ed.
Oxford: Oxford University Press; 1980. p. 241–242.</Citation>
        </Reference>
        <Reference>
          <Citation>Ramos-Vara JA.
Technical aspects of immunohistochemistry. Vet Pathol. 2005;42(4):405–426.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16006601</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kanter M, Uysal T, Kara O.. 
Depression of glucose levels and partial restoration of pancreatic (β) cell damage by melatonin in streptozotozin- induced diabetic rats. Arch Toxicol. 2006;80:362–369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16341692</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carson FL. Histotechnology a self- instructural text. 2nd ed.; 1996; p. 154–156.</Citation>
        </Reference>
        <Reference>
          <Citation>Firestein GS.
Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12748655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee SH, Ye Kwon J, Kim SY, et al. . 
Interferon-gamma regulates inflammatory cell death by targeting necroptosis in experimental autoimmune arthritis. Sci Rep. 2017;7(1):10133.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5579272</ArticleId>
            <ArticleId IdType="pubmed">28860618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jhun J, Lee SH, Kim SY, et al. . 
RIPK1 inhibition attenuates experimental autoimmune arthritis via suppression of osteoclastogenesis. J Transl Med. 2019;17(1):84.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6419814</ArticleId>
            <ArticleId IdType="pubmed">30876479</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meyer O.
Role of TNF-alpha and cytokines in the physiopathology of rheumatoid arthritis. Therapeutic perspectives. Bull Acad Natl Med. 2003;187(5):935–954. PMID:14979058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">14979058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang YJ, Hsu SL, Liu YT, et al. . 
Gallic acid induces necroptosis via TNF–α signaling pathway in activated hepatic stellate cells. PLoS One. 2015;10((3):e0120713. doi:10.1371/journal.pone.0120713.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0120713</ArticleId>
            <ArticleId IdType="pmc">PMC4376672</ArticleId>
            <ArticleId IdType="pubmed">25816210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Berghe TV, Linkermann A, Jouan-Lanhouet S, et al. . 
Regulated necrosis: the expanding network of non-apoptotic cell death pathways. Nat Rev Mol Cell Biol. 2014;15(2):135–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">24452471</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson U, Harris HE.. 
The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta Gene Regul Mech. 2010;1799(1-2):141–148. doi:10.1016/j.bbagrm.2009.11.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbagrm.2009.11.003</ArticleId>
            <ArticleId IdType="pubmed">20123076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Z, Jin Y, Yan H, et al. . 
High-mobility group box 1 protein-mediated necroptosis contributes to dasatinib-induced cardiotoxicity. Toxicol Lett. 2018;296:39–47. doi:10.1016/j.toxlet.2018.08.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.toxlet.2018.08.003</ArticleId>
            <ArticleId IdType="pubmed">30086328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Andersson U, Erlandsson-Harris H.. 
HMGB1 is a potent trigger of arthritis. J Intern Med. 2004;255(3):344–350. doi:10.1111/j.1365-2796.2003.01303.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2796.2003.01303.x</ArticleId>
            <ArticleId IdType="pubmed">14871458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Basok BI, Kucur M, Kizilgul M, et al. . 
Increased Chitotriosidase activities in patients with rheumatoid arthritis: a possible novel marker?
J Med Biochem. 2014;33(3):245–251. doi:10.2478/jomb-2014-0010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2478/jomb-2014-0010</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arhire LI, Mihalache L, Covasa M.. 
Irisin: a hope in understanding and managing obesity and metabolic syndrome. Front Endocrinol (Lausanne). 2019;10:524.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC6687775</ArticleId>
            <ArticleId IdType="pubmed">31428053</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavrova DP, Zavodovsky BV, Akhverdyan YR, et al. . 
Irisin as a new marker for the early diagnosis of low-traumatic fractures in rheumatoid arthritis. Klin Lab Diagn. 2018;63(11):702–706.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">30776205</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vadalà G.
Cross talk between muscle and cartilage: the myokine irisin attenuates osteoarthritis related cartilage degeneration. Orthop Proc. 2018;100(SUPP_15):18–18.</Citation>
        </Reference>
        <Reference>
          <Citation>Dong J, Dong Y, Chen F, et al. . 
Inhibition of myostatin in mice improves insulin sensitivity via irisin-mediated cross talk between muscle and adipose tissues. Int J Obes. 2016;40(3):434.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC4783239</ArticleId>
            <ArticleId IdType="pubmed">26435323</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazur-Bialy AI.
Irisin acts as a regulator of macrophages host defense. Life Sci. 2017;176:21–25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">28315350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gannon NP, Vaughan RA, Garcia-Smith R, et al. . 
Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer. 2015;136(4):E197–E202.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">25124080</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazur-Bialy AI, Pocheć E, Zarawski M.. 
Anti-inflammatory properties of irisin, mediator of physical activity, are connected with TLR4/MyD88 signaling pathway activation. Int J Mol Sci. 2017;18(4):701.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5412287</ArticleId>
            <ArticleId IdType="pubmed">28346354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fan X, Du J, Wang MH, et al. . 
Irisin contributes to the hepatoprotection of dexmedetomidine during intestinal ischemia/reperfusion. Oxid Med Cell Longev. 2019 May 2;2019:7857082. doi:10.1155/2019/7857082.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2019/7857082</ArticleId>
            <ArticleId IdType="pmc">PMC6525857</ArticleId>
            <ArticleId IdType="pubmed">31191804</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olson CM, Hedrick MN, Izadi H, et al. . 
P38 mitogen-activated protein kinase controls NF-κB transcriptional activation and tumor necrosis factor alpha production through RelA phosphorylation mediated by mitogen-and stress-activated protein kinase 1 in response to borrelia burgdorferi antigens. Infect Immun. 2007;75(1):270–277.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1828394</ArticleId>
            <ArticleId IdType="pubmed">17074860</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mazur-Bialy AI, Kozlowska K, Pochec E, et al. . 
Myokine irisin-induced protection against oxidative stress in vitro. Involvement of heme oxygenase-1 and antioxidazing enzymes superoxide dismutase-2 and glutathione peroxidase. J Physiol Pharmacol. 2018;69:117–125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">29769428</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu D, Wang H, Zhang J, et al. . 
Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses. J Mol Cell Cardiol. 2015;87:138–147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">26225842</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lim MA, Louie B, Ford D, et al. . 
Development of the digital arthritis index. A novel metric to measure disease parameters in rat model of rheumatoid arthritis. Front Pharmacol. 2017;8:818.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC5694443</ArticleId>
            <ArticleId IdType="pubmed">29184498</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
